UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluating oral health needs and resources for the sickle cell disease population

International journal of paediatric dentistry, 2023-09, Vol.33 (S2), p.78-80

2023

Volltextzugriff (PDF)

Review article: breath analysis in inflammatory bowel diseases

Alimentary pharmacology & therapeutics, 2015-02, Vol.41 (4), p.329-341

2015

Volltextzugriff (PDF)

Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study

Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (5), p.498-507

2014

Volltextzugriff (PDF)

Prevalence and risk factors of nonalcoholic fatty liver disease in metabolically healthy obese adolescents in the United States: an analysis of national health and nutrition examination survey data

Journal of hepatology, 2017, Vol.66 (1), p.S587-S588

2017

Volltextzugriff (PDF)

Use of non-invasive methods to assess hepatic steatosis and advanced fibrosis in type-1 diabetic patients

Journal of hepatology, 2017, Vol.66 (1), p.S149-S150

2017

Volltextzugriff (PDF)

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in type-2 diabetic patients via non-invasive methods

Journal of hepatology, 2017, Vol.66 (1), p.S150-S150

2017

Volltextzugriff (PDF)

Prevalence of nonalcoholic fatty liver disease in lean adolescents in the United States: an analysis of national health and nutrition examination survey data

Journal of hepatology, 2017, Vol.66 (1), p.S587-S587

2017

Volltextzugriff (PDF)

Letter: volatile metabolomics of exhaled breath or faecal gas? – authors' reply

Alimentary pharmacology & therapeutics, 2015-04, Vol.41 (7), p.704-704

2015

Volltextzugriff (PDF)

Analysis of the breath metabolome in patients with Hepatocellular carcinoma

Journal of hepatology, 2017, Vol.66 (1), p.S457-S458

2017

Volltextzugriff (PDF)

Breathprints of childhood obesity: changes in volatile organic compounds in obese children compared with lean controls

Pediatric obesity, 2015-02, Vol.10 (1), p.23-29

2015

Volltextzugriff (PDF)

Use of ledipasvir/sofosbuvir in patients with advanced chronic kidney disease (eGFR ≤ 30 mL/min): a case series

Journal of hepatology, 2017, Vol.66 (1), p.S721-S722

2017

Volltextzugriff (PDF)

Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation

International journal of organ transplantation medicine, 2016, Vol.7 (1), p.38-45

2016

Volltextzugriff (PDF)

P0508 : Biopsy findings, ACE levels and APRI are similar in patients with sarcoidosis with and without portal hypertension

Journal of hepatology, 2015-04, Vol.62, p.S505-S505

2015

Volltextzugriff (PDF)

Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database

Transplantation proceedings, 2016-12, Vol.48 (10), p.3362-3367

2016

Volltextzugriff (PDF)

Role of Stearoyl-CoA Desaturase (SCD), Key Enzyme in Obesity, in Development of Human Hepatocellular Carcinoma (HCC): Is HCC Expected to Rise With Obesity Epidemic?

The Journal of surgical research, 2013-02, Vol.179 (2), p.309-309

2013

Volltextzugriff (PDF)

Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease

Gut, 2023-03, Vol.72 (3), p.573-580

2023

Volltextzugriff (PDF)

Treatment of Recurrent Hepatitis C Genotype-4 Post-Liver Transplantation with Sofosbuvir plus Simeprevir

International journal of organ transplantation medicine, 2015-01, Vol.6 (2), p.86-86

2015

Volltextzugriff (PDF)

EE376 The Budget Impact of Introducing Multiparametric MRI (mpMRI) As a Monitoring Tool to Identify Non-Responders Undergoing Thyroid Hormone Receptor Treatment for MASH

Value in health, 2024-06, Vol.27 (6), p.S126-S126

2024

Volltextzugriff (PDF)

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement

The lancet. Gastroenterology & hepatology, 2021-10, Vol.6 (10), p.864-873

2021

Volltextzugriff (PDF)

1014 RETINOL-BINDING PROTEIN 4: A PROMISING CIRCULATING MARKER OF LIVER DAMAGE IN CHILDREN WITH NONALCOHOLIC FATTY LIVER DISEASE

Journal of hepatology, 2009, Vol.50, p.S367-S367

2009

Volltextzugriff (PDF)

THU-340 - Use of non-invasive methods to assess hepatic steatosis and advanced fibrosis in type-1 diabetic patients

Journal of hepatology, 2017, Vol.66 (1), p.S149-S150

2017

Volltextzugriff (PDF)

THU-341 - Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in type-2 diabetic patients via non-invasive methods

Journal of hepatology, 2017, Vol.66 (1), p.S150-S150

2017

Volltextzugriff (PDF)

SAT-302 - Prevalence of nonalcoholic fatty liver disease in lean adolescents in the United States: an analysis of national health and nutrition examination survey data

Journal of hepatology, 2017, Vol.66 (1), p.S587-S587

2017

Volltextzugriff (PDF)

SAT-303 - Prevalence and risk factors of nonalcoholic fatty liver disease in metabolically healthy obese adolescents in the United States: an analysis of national health and nutrition examination survey data

Journal of hepatology, 2017, Vol.66 (1), p.S587-S588

2017

Volltextzugriff (PDF)

SAT-318 - Efficacy of avatrombopag compared with placebo across various mean baseline platelet count subgroups- pooled data from 2 Phase 3 studies

Journal of hepatology, 2018-04, Vol.68, p.S751-S751

2018

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(128)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Evaluating oral health needs and resources for the sickle cell disease population

Review article: breath analysis in inflammatory bowel diseases

Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study

Prevalence and risk factors of nonalcoholic fatty liver disease in metabolically healthy obese adolescents in the United States: an analysis of national health and nutrition examination survey data

Use of non-invasive methods to assess hepatic steatosis and advanced fibrosis in type-1 diabetic patients

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in type-2 diabetic patients via non-invasive methods

Prevalence of nonalcoholic fatty liver disease in lean adolescents in the United States: an analysis of national health and nutrition examination survey data

Letter: volatile metabolomics of exhaled breath or faecal gas? – authors' reply

Analysis of the breath metabolome in patients with Hepatocellular carcinoma

Breathprints of childhood obesity: changes in volatile organic compounds in obese children compared with lean controls

Use of ledipasvir/sofosbuvir in patients with advanced chronic kidney disease (eGFR ≤ 30 mL/min): a case series

Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation

P0508 : Biopsy findings, ACE levels and APRI are similar in patients with sarcoidosis with and without portal hypertension

Liver Transplantation for Hepatitis B in Early Adulthood: Analysis of the United Network for Organ Sharing Database

Role of Stearoyl-CoA Desaturase (SCD), Key Enzyme in Obesity, in Development of Human Hepatocellular Carcinoma (HCC): Is HCC Expected to Rise With Obesity Epidemic?

Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease

Treatment of Recurrent Hepatitis C Genotype-4 Post-Liver Transplantation with Sofosbuvir plus Simeprevir

EE376 The Budget Impact of Introducing Multiparametric MRI (mpMRI) As a Monitoring Tool to Identify Non-Responders Undergoing Thyroid Hormone Receptor Treatment for MASH

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement

1014 RETINOL-BINDING PROTEIN 4: A PROMISING CIRCULATING MARKER OF LIVER DAMAGE IN CHILDREN WITH NONALCOHOLIC FATTY LIVER DISEASE

THU-340 - Use of non-invasive methods to assess hepatic steatosis and advanced fibrosis in type-1 diabetic patients

THU-341 - Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in type-2 diabetic patients via non-invasive methods

SAT-302 - Prevalence of nonalcoholic fatty liver disease in lean adolescents in the United States: an analysis of national health and nutrition examination survey data

SAT-303 - Prevalence and risk factors of nonalcoholic fatty liver disease in metabolically healthy obese adolescents in the United States: an analysis of national health and nutrition examination survey data

SAT-318 - Efficacy of avatrombopag compared with placebo across various mean baseline platelet count subgroups- pooled data from 2 Phase 3 studies

Suchergebnisse filtern